John Riley at Newsday has an interesting piece on Rudy Giuliani's role in helping Purdue Pharma preserve its image after the painkiller OxyContin was linked to widespread abuse. When Giuliani spoke out against medical marijuana, I repeatedly cited his work for Purdue Pharma as evidence of his hypocrisy. While I stand by that position, it should be noted that Giuliani's stance on pain management is actually quite good, in and of itself:

The OxyContin debate has been part of a larger fight in which patient advocacy groups that are worried about historic undertreatment of pain have joined with drug companies to argue against regulatory and law enforcement restrictions on painkillers that might unduly restrict their availability.
…

Giuliani was a key ally in that debate. He cast himself as an expert because of his prosecutorial background and his experience with prostate cancer. As part of his work for Purdue, he agreed to chair a group called the Rx Action Alliance, which promoted a "balanced" approach that would address abuse but maintain access for patients…

As the DEA continues its misguided war on pain management specialists, it's really quite refreshing to know that a front-running presidential candidate understands the problem. DEA's overreaction to OxyContin abuse has been disastrous, resulting in the reluctance of doctors nationwide to prescribe pain-relievers to deserving patients. Whether it was his prostate cancer, or the money Purdue paid his firm, something has led him to stand up for patient access and there's nothing wrong with that.

The only remaining question is why Giuliani is so hostile to medical marijuana. The fact pattern is remarkably similar: the stigma resulting from widespread recreational marijuana use has created a climate in which legitimate patients are denied medical access to the drug.

If only medical marijuana patients could afford to hire Giuliani Partners, LLC to help improve their public image…